Search Results - "Cohen, Hillel P"

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes by Cohen, Hillel P., Blauvelt, Andrew, Rifkin, Robert M., Danese, Silvio, Gokhale, Sameer B., Woollett, Gillian

“…Introduction To evaluate the possibility that switching from reference biologic medicines to biosimilars could lead to altered clinical outcomes, including…”
Get full text

Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective by Cohen, Hillel P., Turner, Matthew, McCabe, Dorothy, Woollett, Gillian R.

“…Biosimilars have been available in the USA for over a decade, and in Europe for almost two decades. In that time, biosimilars have become established in the…”
Get full text

Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars by Cohen, Hillel P

“…A bibliometric analysis provided by Hernandez-Vasquez et al. listed the institutions that have published most extensively in the field of biosimilars. Sandoz…”
Get full text

The Importance of Countering Biosimilar Disparagement and Misinformation by Cohen, Hillel P., McCabe, Dorothy

“…Biosimilar use is limited in some healthcare systems because biosimilars are not well understood by many healthcare professionals and patients. The knowledge…”
Get full text

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching by Cohen, Hillel P., Bodenmueller, Wolfram

“…As of 31 December, 2023, 31 observational studies have been published, including a total of 6081 patients who underwent a switch from one biosimilar to another…”
Get full text

Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch by Sagi, Sreedhar, Anjaneya, Pradeep, Kalsekar, Sameer, Kottke, Andrea, Cohen, Hillel P.

“…Background Biosimilars are additional treatment options that are approved based on robust analytical and clinical comparisons with their reference biologic. At…”
Get full text

Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies by Cohen, Hillel P., Hachaichi, Sohaib, Bodenmueller, Wolfram, Kvien, Tore K., Danese, Silvio, Blauvelt, Andrew

“…Background Multiple switches (transitions) between biosimilars of the same reference biologic are now a reality, and they are expected to become more common in…”
Get full text

Maintaining consistent quality and clinical performance of biopharmaceuticals by Lamanna, William C, Holzmann, Johann, Cohen, Hillel P, Guo, Xinghua, Schweigler, Monika, Stangler, Thomas, Seidl, Andreas, Schiestl, Martin

“…Biopharmaceuticals are large protein based drugs which are heterogeneous by nature due to post translational modifications resulting from cellular production,…”
Get more information

Pharmacovigilance of Biologics in a Multisource Environment by Sagi, Sreedhar, Cohen, Hillel P, Woollett, Gillian R

“…It is important that systems are in place to ensure that appropriate and comprehensive records are kept for use of all medications. It is fundamental to an…”
Get full text

Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” by Cohen, Hillel P., Blauvelt, Andrew, Rifkin, Robert M., Danese, Silvio, Gokhale, Sameer B., Woollett, Gillian

Get full text

Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars by Desai, Rishi J., Kim, Seoyoung C., Curtis, Jeffrey R., Bosco, Jaclyn L.F., Eichelberger, Bernadette, Barr, Charles E., Lockhart, Catherine M., Bradbury, Brian D., Clewell, Jerry, Cohen, Hillel P., Gagne, Joshua J.

“…Purpose As more biosimilars become available in the United States, postapproval noninterventional studies describing biosimilar switching and comparing…”
Get full text

Biochemistry of fern spore germination: protease activity in ostrich fern spores by Cohen, H.P, DeMaggio, A.E

“…Protease activities were detected in quiescent and germinating spores of the ostrich fern (Matteuccia struthiopteris [L.] Todaro). Peak endopeptidase,…”
Get full text

Comment on: "Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes"/Authors' Reply by Pires, Antonio, Goyal, Kavitha, Greenspan, Andrew, Cohen, Hillel P, Blauvelt, Andrew, Rifkin, Robert M, Danese, Silvio, Gokhale, Sameer B, Woollett, Gillian

“…In the article, Tweehuysen et al. concluded that "this prospective cohort study shows that treatment with reference infliximab can be open label transitioned…”
Get full text

Biochemistry of Fern Spore Germination: Protease Activity in Ostrich Fern Spores 1 by Cohen, Hillel P., Demaggio, A. E.

“…Protease activities were detected in quiescent and germinating spores of the ostrich fern ( Matteuccia struthiopteris [L.] Todaro). Peak endopeptidase,…”
Get full text

GENERAL OBSERVATIONS AND PROTEOLYTIC ENZYME ACTIVITY IN SPORES OF THE OSTRICH FERN DURING THE PROCESSES OF GERMINATION (AMINOPEPTIDASE, MATTEUCCIA) by COHEN, HILLEL P

“…In vivo images of spore germination in the ostrich fern, Matteuccia struthiopteris (L.) Todaro, were obtained using video-enhanced differential interference…”
Get full text

High-performance liquid chromatographic separation of leghemoglobins from soybean root nodules by Sarath, G, Cohen, H P, Wagner, F W

“…A crude fraction of soybean nodule ferri-leghemoglobin was absorbed onto a commercial DEAE HPLC column at pH 8.0, and resolved into eight isoprotein fractions…”
Get more information

Soybean root nodule ultrastructure during dark-induced stress and recovery by Cohen, H.P, Sarath, G, Lee, K, Wagner, F.Ww

Get full text